Philadelphia gene therapy startup targeting heart disease raises $11M
August 14, 2019 at 10:53 AM EDT
The Temple University spinoff is working on a gene therapy replacement products for a subset of patients with dilated cardiomyopathy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|